Improving follow-up care after abnormal stool tests using patient navigators
Incomplete Follow Up After Positive FIT or Stool DNA Testing: A Multimethod Approach
This study is testing if having a patient navigator helps people with abnormal stool test results get better follow-up care and complete their colonoscopy appointments.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 40 Years to 75 Years |
| Sex | All |
| Sponsor | Case Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Trial ID | NCT03817905 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of a patient navigator in enhancing follow-up care for individuals who have received abnormal results from fecal immunochemical testing (FIT) or stool DNA testing. Participants will meet with a navigator at their colonoscopy appointment to discuss their experiences and any barriers encountered in scheduling and completing the procedure. The study will analyze both participant feedback and electronic medical records to assess the impact of the navigator on colonoscopy utilization. Approximately 30 individuals will be involved in this intervention.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who have received a positive result from a FIT or stool DNA test.
Not a fit: Patients who do not understand English may not benefit from this study due to communication barriers.
Why it matters
Potential benefit: If successful, this approach could significantly improve the rates of colonoscopy follow-up after abnormal stool tests, leading to earlier detection of colorectal issues.
How similar studies have performed: While the specific approach of using patient navigators for this purpose may be novel, similar studies have shown success in improving follow-up care in other medical contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: • Positive test for FIT or sDNA Exclusion Criteria: • Does not understand English
Where this trial is running
Cleveland, Ohio
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States (Recruiting)
Study contacts
- Principal investigator: Gregory Cooper, MD — University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
- Study coordinator: Gregory Cooper, MD
- Email: CTUReferral@UHhospitals.org
- Phone: 1-800-641-2422
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.